7 Results

People

  1. Solit
    Solit
  2. Rosen
    Rosen
  3. Chandarlapaty
    Chandarlapaty
  4. Sawai
    Sawai
  5. Ye
    Ye
  6. Baumgartner
    Baumgartner
  7. Benezra
    Benezra
  8. Benezra
    Benezra
  9. Cartegni
    Cartegni
  10. Chin
    Chin

Groups

  1. Department of Medicine (7)
  2. GSK Faculty (7)
  3. Genitourinary Oncology Service (7)
  4. Human Oncology and Pathogenesis Program (7)
  5. Solid Tumor Oncology Division (7)
  6. Breast Medicine Service (5)
  7. Molecular Pharmacology and Chemistry Program Faculty (5)
  8. Sloan Kettering Institute Faculty (5)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)
  10. Biostatistics Service (1)
  1. "nonhuman"
  2. "Journal article"
  3. "2008"
  4. "David Solit"
Formats
  1. Journal Article (7)
Groups
  1. Department of Medicine (7)
  2. GSK Faculty (7)
  3. Genitourinary Oncology Service (7)
  4. Human Oncology and Pathogenesis Program (7)
  5. Solid Tumor Oncology Division (7)
  6. Breast Medicine Service (5)

More Groups

People
  1. David Solit (7)
  2. Neal Rosen (5)
  3. Ayana Sawai (2)
  4. Qing Ye (2)
  5. Sarat Chandarlapaty (2)
  6. Christine Pratilas (1)

More People

Years
  1. 2008 (7)
Publications
  1. Cancer Research (1)
  2. Clinical Cancer Research (1)
  3. Current Opinion in Pharmacology (1)
  4. Journal of Clinical Endocrinology and Metabolism (1)
  5. Molecular Carcinogenesis (1)
  6. Nature Biotechnology (1)

More Publications

Publishers
  1. American Association for Cancer Research (2)
  2. Elsevier Inc. (1)
  3. John Wiley & Sons (1)
  4. Nature Publishing Group (1)
  5. Oxford University Press (1)
  6. Wiley Blackwell (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel
    Journal Article

    Sawai, A.; Chandarlapaty, S.; Greulich, H.; Gonen, M.; Ye, Q.; Arteaga, C. L.; Sellers, W.; Rosen, N.; Solit, D. B.
    Cancer Research (2008)

    Fulltext@MSK | Save
  • The current state of preclinical prostate cancer animal models
    Journal Article

    Pienta, K. J.; Abate-Shen, C.; Agus, D. B.; Attar, R. M.; Chung, L. W. K.; Greenberg, N. M.; Hahn, W. C.; Isaacs, J. T.; Navone, N. M.; Peehl, D. M.; more...
    Prostate (2008)

    Fulltext@MSK | Save
  • BRAFV600E mutation is associated with preferential sensitivity to mitogen-activated protein kinase kinase inhibition in thyroid cancer cell lines
    Journal Article

    Leboeuf, R.; Baumgartner, J. E.; Benezra, M.; Malaguarnera, R.; Solit, D.; Pratilas, C. A.; Rosen, N.; Knauf, J. A.; Fagin, J. A.
    Journal of Clinical Endocrinology and Metabolism (2008)

    Fulltext@MSK | Save
  • Peptide-conjugated antisense oligonucleotides for targeted inhibition of a transcriptional regulator in vivo
    Journal Article

    Henke, E.; Perk, J.; Vider, J.; De Candia, P.; Chin, Y.; Solit, D. B.; Ponomarev, V.; Cartegni, L.; Manova, K.; Rosen, N.; more...
    Nature Biotechnology (2008)

    Fulltext@MSK | Save
  • Therapeutic strategies for inhibiting oncogenic BRAF signaling
    Journal Article

    Halilovic, E.; Solit, D. B.
    Current Opinion in Pharmacology (2008)

    Fulltext@MSK | Save
  • SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase - Dependent cancers
    Journal Article

    Chandarlapaty, S.; Sawai, A.; Ye, Q.; Scott, A.; Silinski, M.; Huang, K.; Fadden, P.; Partdrige, J.; Hall, S.; Steed, P.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • The 20th Aspen Cancer Conference: Mechanisms of toxicity, carcinogenesis, cancer prevention, and cancer therapy 2005
    Journal Article

    Bishop, J. M.; Hanahan, D.; Tlsty, T.; Hunter, T.; Lowe, S.; Varmus, H.; Dornbush, K. T.; Waring, J. F.; Jacks, T.; Gilmer, T.; more...
    Molecular Carcinogenesis (2008)

    Fulltext@MSK | Save